PRECISION-Panc network receives major investment

Cancer Research has announced today (24 March 2017) that it will be investing £10M in pancreatic cancer studies being led by researchers here at the Beatson and the University of Glasgow, and in collaboration with scientists and clinicians in Cambridge, Manchester, Oxford and the ICR in London. This investment in the PRECISION-Panc network will support two clinical trials, preclinical work, assay development, biomarker work and a large amount of molecular sequencing.

See more details here:

CRUK Website:


Press release: